This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
As a class-action lawsuit gets rolling in California over the use of ambient AI in healthcare, a national law firm is drawing takeaways for hospitals and other provider organizations. Makes sense: All AI-equipped providers are potential targets for similar litigation now.
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized.
In hospitals serving mentally unstable patients, it’s no easy job to balance sensitive patient treatment with effective worker safety. One U.S. institution has been finding out just how hard it can be.
Manufacturer ICU Medical is aware of the issue, which stems from a report from an unnamed healthcare organization. The company and the FDA are asking providers to monitor IV lines for any signs of particulates.
The Women’s Choice Award is out with its 2024 lists of best hospitals for women across 19 categories, from bariatrics and cancer care to stroke care and women’s services.
“We identified a problem in cardiology,” one cardiologist explained. “Heart imaging has made remarkable progress in recent decades, but the electrics of the heart have eluded us."
Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective.
More than two-thirds of hospital executives, 70%, say their institution has a formal or comprehensive strategy in place for selecting, acquiring and integrating digital health products.
Abbott's HeartMate 3 LVAD is the only FDA-approved device of its kind currently available in the United States. Should reports of adverse events worry cardiologists? Or are they to be expected when treating such a vulnerable patient population?
While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.